Chatterjee Kanu, Massie Barry
Cardiology Division, University of California, San Francisco, CA 94143-0124, USA.
J Card Fail. 2007 Sep;13(7):569-76. doi: 10.1016/j.cardfail.2007.04.006.
Diastolic heart failure (DHF) and systolic heart failure (SHF) are 2 clinical subsets of the syndrome of chronic heart failure that are most commonly encountered in clinical practice.
The clinically overt DHF and SHF appear to be 2 separate syndromes with distinctive morphologic and functional changes although signs, symptoms, and prognosis are very similar. In DHF, the left ventricle is not dilated and the ejection fraction is preserved. In contrast in SHF, it is dilated and the ejection fraction is reduced. The neurohormonal abnormalities in DHF and SHF appear to be similar. The stimuli and the signals that ultimately produce these 2 different phenotypes of chronic heart failure remain, presently, largely unknown.
Although there has been considerable progress in the management of SHF, the management of DHF remains mostly empirical because of lack of knowledge of the molecular and biochemical mechanisms which produce myocardial structural and functional changes in this syndrome. Further research and investigations are urgently required.
舒张性心力衰竭(DHF)和收缩性心力衰竭(SHF)是慢性心力衰竭综合征的两个临床亚组,在临床实践中最为常见。
临床上明显的DHF和SHF似乎是两种不同的综合征,具有独特的形态学和功能变化,尽管体征、症状和预后非常相似。在DHF中,左心室不扩张,射血分数保留。相比之下,在SHF中,左心室扩张且射血分数降低。DHF和SHF中的神经激素异常似乎相似。目前,最终导致慢性心力衰竭这两种不同表型的刺激因素和信号在很大程度上仍不清楚。
尽管在SHF的管理方面取得了相当大的进展,但由于缺乏对该综合征中产生心肌结构和功能变化的分子和生化机制的了解,DHF的管理大多仍基于经验。迫切需要进一步的研究和调查。